These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 18026741)

  • 21. Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice.
    Chi L; Ke Y; Luo C; Li B; Gozal D; Kalyanaraman B; Liu R
    Stem Cells; 2006 Jan; 24(1):34-43. PubMed ID: 16099995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
    Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
    Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immunity in amyotrophic lateral sclerosis.
    Moisse K; Strong MJ
    Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
    Yamanaka K; Miller TM; McAlonis-Downes M; Chun SJ; Cleveland DW
    Ann Neurol; 2006 Jul; 60(1):95-104. PubMed ID: 16802286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain.
    Liu Z; Martin LJ
    J Comp Neurol; 2006 Jul; 497(3):468-88. PubMed ID: 16736475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic models of amyotrophic lateral sclerosis.
    Grieb P
    Folia Neuropathol; 2004; 42(4):239-48. PubMed ID: 15679043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALS: a disease of motor neurons and their nonneuronal neighbors.
    Boillée S; Vande Velde C; Cleveland DW
    Neuron; 2006 Oct; 52(1):39-59. PubMed ID: 17015226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in amyotrophic lateral sclerosis research.
    Przedborski S; Mitsumoto H; Rowland LP
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):70-7. PubMed ID: 12507415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular mechanisms of ALS-linked mutant SOD1-induced motor neuron death].
    Nishitoh H; Ichijo H
    Tanpakushitsu Kakusan Koso; 2009 Mar; 54(3):237-44. PubMed ID: 19288861
    [No Abstract]   [Full Text] [Related]  

  • 34. Are all new data referring to amyotrophic lateral sclerosis certain? Some doubts.
    Rafałowska J
    Folia Neuropathol; 2001; 39(4):261-4. PubMed ID: 11928897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.
    Gois AM; Mendonça DMF; Freire MAM; Santos JR
    Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS.
    Park JH; Park HS; Hong S; Kang S
    Exp Mol Med; 2016 Dec; 48(12):e276. PubMed ID: 27932790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.
    Goodall EF; Morrison KE
    Expert Rev Mol Med; 2006 May; 8(11):1-22. PubMed ID: 16723044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life.
    Brooks BR
    Ann Neurol; 2009 Jan; 65 Suppl 1():S17-23. PubMed ID: 19191306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed cell death in amyotrophic lateral sclerosis.
    Guégan C; Przedborski S
    J Clin Invest; 2003 Jan; 111(2):153-61. PubMed ID: 12531867
    [No Abstract]   [Full Text] [Related]  

  • 40. [Familial Amyotrophic Lateral Sclerosis].
    Suzuki N; Nishiyama A; Kato M; Warita H; Aoki M
    Brain Nerve; 2019 Nov; 71(11):1169-1181. PubMed ID: 31722303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.